Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson B Rodrigues

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Affective Disorders|May 9, 2021
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine TreatmentRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 28, 2021
Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic reviewAshley N Siegel, Joshua D Di Vincenzo, Elisa Brietzke, et al.
Bipolar Disorders|December 14, 2022
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Journal of Psychopharmacology (Oxford, England)|October 12, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of ExcellenceRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Journal of Affective Disorders|May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic ReviewHartej Gill, Sabine El-Halabi, Amna Majeed, et al.
JMIR Mental Health|October 27, 2022
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation StudyRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2024
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depressionDanica E Johnson, Nelson B Rodrigues, Sydney Weisz, et al.
Journal of Affective Disorders|September 1, 2022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic reviewAnastasia Levinta, Shakila Meshkat, Roger S McIntyre, et al.
Journal of Affective Disorders|January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusionsNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Affective Disorders|May 9, 2021
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine TreatmentRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 28, 2021
Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic reviewAshley N Siegel, Joshua D Di Vincenzo, Elisa Brietzke, et al.
Bipolar Disorders|December 14, 2022
Real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Journal of Psychopharmacology (Oxford, England)|October 12, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of ExcellenceRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Focus (American Psychiatric Publishing)|May 2, 2024
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar DepressionFarhan Fancy, Nelson B Rodrigues, Joshua D Di Vincenzo, et al.
Journal of Affective Disorders|May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic ReviewHartej Gill, Sabine El-Halabi, Amna Majeed, et al.
JMIR Mental Health|October 27, 2022
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation StudyRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2024
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depressionDanica E Johnson, Nelson B Rodrigues, Sydney Weisz, et al.
Journal of Affective Disorders|September 1, 2022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic reviewAnastasia Levinta, Shakila Meshkat, Roger S McIntyre, et al.
Journal of Affective Disorders|January 8, 2021
A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusionsNelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Pageof 7